A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs
Substance Use · HIV Prevention
What this study involves
The registry does not currently label this study as recruiting. Ask about its status before planning a screening visit.
- Study type
- Interventional
- Phase
- Not applicable
- Age range
- 18 years - Not specified
- Sex eligible
- All sexes
- Healthy volunteers
- Not accepted
- Participants
- 398 Estimated
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
This study includes finalization of the LINKED social network intervention to improve PrEP and MOUD uptake among people who inject drugs (PWID) in collaboration with an Expert Advisory Board and staff (N=16) at The Sidewalk Project (TSP), followed by a Hybrid Type II cluster randomized trial of the LINKED intervention (versus an equal-attention control) among N=372 people who inject drugs, with 6- and 12-month follow-up assessment of PrEP and MOUD uptake. The investigators will also evaluate implementation outcomes to inform future sustainable implementation of LINKED in harm reduction organizations.
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
Aim 1 - Virtual Focus Group
- Is 18 years or older
- Is a current TSP staff
- Is capable and willing to provide consent
Aim 2 - Intervention
- 18 years or older
- Spend majority of their time in the Los Angeles, CA area where recruited
- Able to complete surveys and group sessions in English
- Self-report to have injected drugs in the past 3 months
- Self-reported HIV negative serostatus
- Not currently on PrEP or MOUD
- Not pregnant
- If a network recruit: presents a valid recruitment coupon
- Is capable and willing to provide consent
Aim 3 - Virtual Focus Group/Surveys
- Is 18 years or older
- Is a current TSP staff
- Is capable and willing to provide consent
Exclusion Criteria:
Aims 1 and 3:
• Individuals who are not current TSP staff members will be excluded from participation.
Aim 2:
- Under age 18;
- Does not spend majority of time in the Los Angeles, CA area where recruited;
- Unable to complete surveys and groups sessions in English;
- Does not self-report injecting drugs in past 3 months;
- Self-reported HIV positive serostatus
- Currently on PrEP or MOUD
- Currently pregnant
- If a network recruit: does not present a valid recruitment coupon
Treatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Random assignment
- Masking
- No masking
LINKED Intervention
Participants randomized to the LINKED arm will receive a peer change agent intervention consisting of a 3-hour workshop divided into four learning and practice modules.
Behavioral: LINKED
Equal-Attention Control
Participants randomized to the equal attention control group will receive a group intervention facilitated by trained study staff.
Behavioral: Group Intervention
LINKED BEHAVIORAL
LINKED is a theory-driven social network intervention (SNI) that leverages peer influence within the social networks of people who inject drugs (PWID) to disseminate information, encourage communication, and increase pre-exposure prophylaxis (PrEP) and medications for opioid use disorder (MOUD) uptake and persistence in harm reduction organization (HRO) settings.
Group Intervention BEHAVIORAL
Group intervention facilitated by trained study staff that supports critical thinking about what constitutes low, medium, and high risks for HIV and overdose.
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
Percentage of Participants with PrEP Uptake
Time frame: Month 6
Measured via filled PrEP prescription.
Percentage of Participants with PrEP Uptake
Time frame: Month 12
Measured via filled PrEP prescription.
Percentage of Participants with MOUD Uptake
Time frame: Month 6
Measured via filled MOUD prescription or buprenorphine, methadone, or naltrexone enrollment.
Percentage of Participants with MOUD Uptake
Time frame: Month 12
Measured via filled MOUD prescription or buprenorphine, methadone, or naltrexone enrollment.
Percentage of Participants with PrEP Adherence
Time frame: Month 6
Measured via urine immunoassays to test for oral PrEP.
Percentage of Participants with PrEP Adherence
Time frame: Month 12
Measured via urine immunoassays to test for oral PrEP.
Percentage of Participants with MOUD Adherence
Time frame: Month 6
Measured via urinalysis to test for metabolites for MOUD.
Percentage of Participants with MOUD Adherence
Time frame: Month 12
Measured via urinalysis to test for metabolites for MOUD.
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (3)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
3 locations
University of Southern CaliforniaLos Angeles, California, United StatesStatus unknown
The University of ChicagoChicago, Illinois, United StatesStatus unknown
NYU Langone HealthNew York, New York, United StatesStatus unknown
Study team and timeline
- Lead sponsor
- NYU Langone Health
- Study start
- Jan 1, 2027 Estimated
- Primary completion
- Dec 1, 2028 Estimated
- Study completion
- Dec 1, 2028 Estimated
- First posted
- Feb 13, 2026 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
Official study title
A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 12, 2026 · Last registry update: Nov 10, 2026
